Betmiga 50 mg, Retardtabletten

7680627550053 CH-62755 Tabletten

Associated product:

BETMIGA cpr ret 50 mg 30 pce
Betmiga 50 mg, Retardtabletten
Betmiga 50 mg, Retardtabletten
Betmiga 50 mg, Retardtabletten
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
29/10/2019
Summary of Product Characteristics
Français
29/10/2019
Summary of Product Characteristics
Italien
29/10/2019
Patient information leaflet
Allemand
20/07/2016
Patient information leaflet
Français
20/07/2016
Patient information leaflet
Italien
20/07/2016

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance ANTOX

Reimbursement information

Public price
CHF 53.65
Specialties list
Yes
Generic
No
SL addition date: 01/07/2014

Authorization holder

Astellas Pharma AG

8304 Wallisellen

Authorization information

Swissmedic authorization number
62755
Drug name
Betmiga, Retardtabletten
Galenic form
RETT
ATC Code
G04BD12
Authorization status
Z
Dispensing category
B
First authorization
19/05/2014
Authorization expiration date
31/12/9999
IT Number
05.02.0.
Domain
Human medicine
Field of application
Symptomatische Behandlung der hyperaktiven Blase (OAB)

Package details

Description (FR)
BETMIGA cpr ret 50 mg 30 pce
Description (DE)
BETMIGA Ret Tabl 50 mg 30 Stk
Market launch
19/05/2014
Narcotic (BTM)
No

Other package sizes (5)

BETMIGA cpr ret 25 mg 10 pce
10 TABL
GTIN: 7680627550015
View
BETMIGA cpr ret 25 mg 30 pce
30 TABL
GTIN: 7680627550022
View
BETMIGA cpr ret 25 mg 90 pce
90 TABL
GTIN: 7680627550039
View
BETMIGA cpr ret 50 mg 10 pce
10 TABL
GTIN: 7680627550046
View
BETMIGA cpr ret 50 mg 90 pce
90 TABL
GTIN: 7680627550060
View